Avalon GloboCare Corp.·4

Jul 13, 4:31 PM ET

Mathews Michael 4

Research Summary

AI-generated summary

Updated

Avalon GloboCare (ALBT) Director Michael Mathews Receives Award

What Happened Michael Mathews, a director of Avalon GloboCare Corp. (ALBT), was granted a derivative award covering 100,000 shares on June 29, 2026. The award is reported as a derivative acquisition (transaction code A) with $0 paid on acquisition. According to the filing, the option/share award vested in full on the grant date.

Key Details

  • Transaction date: 2026-06-29 (grant); Form 4 filed: 2026-07-13 (appears late relative to the 2‑business‑day reporting rule).
  • Instrument: Derivative award/option for 100,000 shares; acquisition price shown as $0.00.
  • Vesting: Footnote states 100% of the shares subject to the option vested in full on the grant date.
  • Shares owned after transaction: Not specified in the filing.
  • Filing timeliness: Filing date is 14 days after the transaction date, which suggests a late filing.

Context This was an equity award (option/derivative) granted and fully vested immediately—no cash outlay reported. Award grants that vest on the grant date generally increase an insider’s potential ownership but do not necessarily indicate an immediate purchase or sale of stock. The late filing does not change the substance of the award but can delay public visibility of the insider’s change in potential ownership.